ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,667.20
      0.64%
      US Tech 100
      19,600.00
      -1.28%
      Dow Jones
      40,954.48
      1.85%
      Brent Oil
      83.425
      0.13%
      Bitcoin
      65,359.59
      0.41%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Harmony Biosciences Holdings Inc (HRMY)

      7. Harmony Biosciences Holdings Inc (HRMY) Financials

      Harmony Biosciences Holdings Inc

      Harmony Biosciences Holdings Inc (HRMY)

      NASDAQ
      34.71
      0.70
      (2.06%)
      Closed July 16 4:00PM
      Delayed by 15 minutes
      34.71
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Harmony Biosciences Holdings Inc Financial Summary

      The current HRMY market cap is 1.97B. The company's latest EPS is USD 2.2689 and P/E is 15.30.

      Income Statement

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 119.13M134.22M160.27M168.41M154.62M
      Operating Income 40.42M46.9M64.36M40.2M52.03M
      Net Income 29.49M34.3M38.46M26.61M38.33M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 6M159.74M305.44M437.86M582.02M
      Operating Income -145.9M16.99M87.53M120.19M192.03M
      Net Income -187.21M-63.85M34.6M181.47M128.85M

      Balance Sheet

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 715.09M760.18M777.77M811.45M846.99M
      Total Liabilities 272.05M275.01M296.43M344.46M331.59M
      Total Equity 443.04M485.17M481.33M466.99M515.39M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 106.7M427.07M433.44M673.87M811.45M
      Total Liabilities 118.29M329.89M246.94M271.03M344.46M
      Total Equity -422.86M97.18M186.51M402.84M466.99M

      Cash Flow

      Annual Quarterly
      Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating 42.56M79.07M142.72M219.39M31.14M
      Investing -1.79M-9.56M-10.37M-46.44M-6.19M
      Financing 3.41M3.07M-52.03M-105.55M-3.63M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -75.44M-2.99M98.56M144.47M219.39M
      Investing -127.15M-2M-100.3M-141.83M-46.44M
      Financing 143.77M209.16M7.42M6.84M-105.55M

      Stats and Ratios

      Market Cap 1.97B
      Price to Earnings Ratio 15.30
      Price to Sales Ratio 3.39
      Price to Cash Ratio 6.32
      Price to Book Ratio 4.22
      Dividend Yield -

      Share Statistics

      Shares Outstanding 56.79M
      Average Volume (1 week) 484.37k
      Average Volume (1 Month) 514.42k
      52 Week Change -2.31%
      52 Week High 39.265
      52 Week Low 18.6112
      Spread (Intraday) 2.98 (8.28%)

      Company Info

      Company Name Harmony Biosciences Holdings Inc
      Address 1209 orange street
      wilmington, delaware 19801
      Website https://www.harmonybiosciences.com
      Industry pharmaceutical preparations (2834)